Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the continued supply of Degaralix for the treatment of patients with advanced prostate cancer.
The Department fully understands that maintaining access to degarelix (Firmagon) injection is vitally important to many people in this country.
We are currently not aware of any supply issues with degarelix injection from Ferring Pharmaceuticals Ltd and supplies are currently available.
We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.